Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.

@article{Reed2004PostmenopausalEA,
  title={Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.},
  author={Susan D L Reed and Kara L. Cushing-Haugen and Janet R. Daling and D. Tyler Scholes and Stephen M Schwartz},
  journal={Menopause},
  year={2004},
  volume={11 2},
  pages={214-22}
}
OBJECTIVE Leiomyomas are common benign neoplasms. Although hormone therapy is the most common and effective treatment for menopausal symptoms, little is known about its effect on leiomyomas. We examined the risk of a first diagnosis of leiomyomas in peri- and postmenopausal women associated with prior use of estrogen and progestogen therapy (EPT). DESIGN A case-control study was conducted among enrollees from a nonprofit health plan. Cases had a first diagnosis of leiomyomas confirmed by… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…